Allegiance Financial Group Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Allegiance Financial Group Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Sell	19,450 -1,173	-6%	-$67.4K	0.19%	45
2026 Q1	$1.25M	Buy	20,623 +3,204	+18%	+$187K	0.25%	39
2025 Q4	$940K	Buy	17,419 +11,649	+202%	+$560K	0.2%	47
2025 Q3	$260K	Buy	5,770 +987	+21%	+$46.1K	0.06%	134
2025 Q2	$221K	Sell	4,783 -394	-8%	-$19.3K	0.06%	138
2025 Q1	$316K	Buy	5,177 +365	+8%	+$21.3K	0.1%	88
2024 Q4	$272K	Buy	4,812 +92	+2%	+$5.14K	0.09%	72
2024 Q3	$244K	Buy	+4,720	New	+$221K	0.09%	66
2023 Q4	–	Sell	-3,728	Closed	-$216K	–	68
2023 Q3	$216K	Buy	3,728 +1	+0%	+$61	0.12%	58
2023 Q2	$238K	Buy	3,727 +1	+0%	+$67	0.14%	56
2023 Q1	$258K	Hold	3,726	–	–	0.19%	53
2022 Q4	$268K	Buy	+3,726	New	+$281K	0.26%	53

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Allegiance Financial Group Advisory Services's BMY Position: Q2 2026 in Review

Allegiance Financial Group Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 5.7% in Q2 2026, selling an estimated $67.4K and leaving 19,450 shares worth $1.12M. The position accounts for 0.19% of the portfolio, ranked #45.

Allegiance Financial Group Advisory Services first reported a position in BMY in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.25M in Q1 2026. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Allegiance Financial Group Advisory Services held 19,450 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
Allegiance Financial Group Advisory Services sold 1,173 Bristol-Myers Squibb shares in Q2 2026, an estimated $67.4K.
Bristol-Myers Squibb made up 0.19% of Allegiance Financial Group Advisory Services's portfolio in Q2 2026, its #45 holding.
Allegiance Financial Group Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 12 quarters since.
Allegiance Financial Group Advisory Services's Bristol-Myers Squibb position peaked at $1.25M in Q1 2026.
888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Allegiance Financial Group Advisory Services's 13F filing for Q2 2026, filed 27 Jul 2026.